Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Soluble aggregates presen… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression

Artikel i vetenskaplig tidskrift
Författare S. De
D. R. Whiten
F. S. Ruggeri
C. Hughes
M. Rodrigues
D. I. Sideris
C. G. Taylor
F. A. Aprile
S. Muyldermans
T. P. J. Knowles
M. Vendruscolo
C. Bryant
Kaj Blennow
Ingmar Skoog
Silke Kern
Henrik Zetterberg
D. Klenerman
Publicerad i Acta Neuropathologica Communications
Volym 7
ISSN 2051-5960
Publiceringsår 2019
Publicerad vid Institutionen för neurovetenskap och fysiologi
Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Språk en
Länkar dx.doi.org/10.1186/s40478-019-0777-...
Ämnesord Alzheimer's disease, Mild cognitive impairment, Cerebrospinal fluid, Protein aggregation, Structure-function relation, Super-resolution imaging, Disease mechanism, a-beta oligomer, amyloid-beta, cellular toxicity, ca2+ influx, amyloid-beta(1-42), epitope, dimers, Neurosciences & Neurology
Ämneskategorier Neurovetenskaper

Sammanfattning

Soluble aggregates of amyloid-beta (A beta) have been associated with neuronal and synaptic loss in Alzheimer's disease (AD). However, despite significant recent progress, the mechanisms by which these aggregated species contribute to disease progression are not fully determined. As the analysis of human cerebrospinal fluid (CSF) provides an accessible window into the molecular changes associated with the disease progression, we characterised soluble aggregates present in CSF samples from individuals with AD, mild cognitive impairment (MCI) and healthy controls using a range of sensitive biophysical methods. We used super-resolution imaging and atomic force microscopy to characterise the size and structure of the aggregates present in CSF and correlate this with their ability to permeabilise lipid membranes and induce an inflammatory response. We found that these aggregates are extremely heterogeneous and exist in a range of sizes, varying both structurally and in their mechanisms of toxicity during the disease progression. A higher proportion of small aggregates of A beta that can cause membrane permeabilization are found in MCI CSF; in established AD, a higher proportion of the aggregates were larger and more prone to elicit a pro-inflammatory response in glial cells, while there was no detectable change in aggregate concentration. These results show that large aggregates, some longer than 100nm, are present in the CSF of AD patients and suggest that different neurotoxic mechanisms are prevalent at different stages of AD.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?